Pfizer To Buy Incyte

November 20, 2005

104

Pfizer Inc. is set to pay Incyte Corp. as much as $803 million for the development, manufacture and marketing rights of drugs to treat chronic inflammatory conditions, the companies said on Monday.

*For more on this story,

read the full Reuters article.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

Unlimited access to OCBJ.com
Daily OCBJ Updates delivered via email each weekday morning
Journal issues in both print and digital format
The annual Book of Lists: industry of Orange County's leading companies
Special Features: OC's Wealthiest, OC 500, Best Places to Work, Charity Event Guide, and many more!

REAL ESTATE DEALS

National Office Markets

staff-author

Pfizer To Buy Incyte

Want more from the best local business newspaper in the country?

Would you like to subscribe to Orange County Business Journal?

Featured Articles

Rivian Rolls Out New AI Assistant to R1 Vehicles

Midday Stock Roundup: Skyworks Solutions Falls

Ducommun Earnings Top Estimates

Related Articles

Rivian Rolls Out New AI Assistant to R1 Vehicles

Midday Stock Roundup: Skyworks Solutions Falls

Ducommun Earnings Top Estimates

Viant Technology Reports 25% Jump in Revenue

Anduril Picks Rocket Lab for $30M Contract

Advertise With Us

About Us

Subscriber Links

Other Journals